IBDEI140 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18524,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,18524,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,18525,0)
 ;;=E13.9^^94^908^22
 ;;^UTILITY(U,$J,358.3,18525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18525,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,18525,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,18525,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,18526,0)
 ;;=E16.2^^94^908^29
 ;;^UTILITY(U,$J,358.3,18526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18526,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,18526,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,18526,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,18527,0)
 ;;=E20.0^^94^908^34
 ;;^UTILITY(U,$J,358.3,18527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18527,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,18527,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,18527,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,18528,0)
 ;;=E20.9^^94^908^30
 ;;^UTILITY(U,$J,358.3,18528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18528,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,18528,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,18528,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,18529,0)
 ;;=E23.0^^94^908^31
 ;;^UTILITY(U,$J,358.3,18529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18529,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,18529,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,18529,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,18530,0)
 ;;=E27.1^^94^908^51
 ;;^UTILITY(U,$J,358.3,18530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18530,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,18530,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,18530,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,18531,0)
 ;;=E27.2^^94^908^1
 ;;^UTILITY(U,$J,358.3,18531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18531,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,18531,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,18531,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,18532,0)
 ;;=E27.3^^94^908^23
 ;;^UTILITY(U,$J,358.3,18532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18532,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,18532,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,18532,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,18533,0)
 ;;=E29.1^^94^908^52
 ;;^UTILITY(U,$J,358.3,18533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18533,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,18533,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,18533,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,18534,0)
 ;;=E55.9^^94^908^59
 ;;^UTILITY(U,$J,358.3,18534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18534,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,18534,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,18534,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,18535,0)
 ;;=E66.01^^94^908^38
 ;;^UTILITY(U,$J,358.3,18535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18535,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,18535,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,18535,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,18536,0)
 ;;=E66.8^^94^908^42
 ;;^UTILITY(U,$J,358.3,18536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18536,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,18536,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,18536,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,18537,0)
 ;;=E66.9^^94^908^43
 ;;^UTILITY(U,$J,358.3,18537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18537,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,18537,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,18537,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,18538,0)
 ;;=E74.39^^94^908^35
